"GLIMITERIS TRIO: Tailored Diabetes Care"

Mar 13, 2024

GLIMITERIS TRIO

Voglibose 0.2 - 0.3mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

The combination of Voglibose, Glimepiride, and Metformin Hydrochloride in a single medication, often referred to as GLIMITERIS TRIO, is an innovative approach to the management of type 2 diabetes. This particular formulation combines three active ingredients, each with a unique mechanism of action, to provide a comprehensive treatment solution.

Mechanism of Action:

  • Voglibose: Acts as an alpha-glucosidase inhibitor, which slows down carbohydrate digestion and absorption, reducing postprandial blood glucose spikes.
  • Glimepiride: A sulfonylurea that increases insulin secretion from the pancreas, thereby lowering blood sugar levels.
  • Metformin Hydrochloride: Improves glucose tolerance, increases insulin sensitivity, and decreases hepatic glucose production.

Benefits:

  • Enhanced Glucose Control: The synergistic effect of the three components helps in better management of blood glucose levels.
  • Convenience: Single-pill combination enhances compliance compared to taking multiple medications separately.
  • Reduced Side Effects: Lower doses of each component may reduce the risk of side effects.

Considerations:

  • Individualized Treatment: Dosage should be adjusted based on the patient's response and tolerance.
  • Monitoring: Regular monitoring of blood glucose and hemoglobin A1c levels is recommended to assess efficacy.

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

This variant of GLIMITERIS TRIO is slightly adjusted with a lower dose of Voglibose, designed to cater to patients who may need a less aggressive approach to postprandial glucose management or who may be more sensitive to the effects of Voglibose.

Mechanism of Action:

  • Voglibose (0.2 mg): Provides a milder inhibition of alpha-glucosidase, making it suitable for those sensitive to gastrointestinal side effects.
  • Glimepiride (3 mg) & Metformin Hydrochloride (500 mg): Remain the same, working in tandem to improve insulin secretion and sensitivity while reducing hepatic glucose production.

Benefits:

  • Flexibility in Glucose Management: Tailored for patients requiring adjustments in their postprandial glucose control.
  • Improved Tolerability: Lower Voglibose dose reduces the risk of gastrointestinal discomfort, a common side effect.
  • Comprehensive Control: Maintains the advantages of a multi-mechanism approach to diabetes management.

Considerations:

  • Patient Selection: Ideal for patients who experienced side effects with higher doses of Voglibose or those with less severe postprandial glucose spikes.
  • Adaptability: Allows for easy adjustment of therapy based on patient response and tolerance.

Conclusion:

The GLIMITERIS TRIO formulations provide a versatile and effective solution for the management of type 2 diabetes, catering to a broad spectrum of patient needs. Whether it's the more potent combination with 0.3 mg of Voglibose or the milder 0.2 mg option, these medications offer a balanced approach to controlling blood glucose levels, improving patient compliance, and potentially reducing the risk of diabetes-related complications. As with any medication regimen, individual responses can vary, and treatment should be personalized to achieve optimal outcomes. A group of highly skilled pharmaceutical professionals founded a specialist pharmaceutical in February 2018 such as Steris Healthcare Pvt Ltd.Sterispharma is a WHO, GMP, and ISO-certified pharma company based in Navi Mumbai. They provide quality medicines at the best price to customers in India as per the standard parameters of WHO. With a steris online pharmacy, you can buy and get home delivery of medicines at your doorsteps. Our main goal at Steris is to provide a wide range of healthcare goods to meet the various needs of the healthcare sector. Steris is dedicated to satisfying the needs of the healthcare industry, whether it be with regard to specialty treatments, rare disease meds, or necessary pharmaceuticals. Steris healthcare products range covers almost every cadre of requirement in today's Medical scenario, widely prescribed under categories like Cardiology, Asthama, Respiratory, Nasal, Diabetic, Endocrinology, Cadiology, Gastrology, Orthopaedic, Anti-infective/antibiotic, General, Urology, Neurology, Nephrology, Oncology, Gynaecology, Pediatric, Dental & Derma range of Products.

For further more information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL:: 7877551268, 8209542042, 8955945010, 6377716668   

WHATSAPP:: MONA, HARSHITA, SAKSHI, SHWETA   

BUY NOW

 

 

 

 

 

SHARE WITH